Cardiac adiposity and cardiovascular risk: Potential role of epicardial adipose tissue

Current Cardiology Reviews

Volumn 3, Issue 1, 2007, Pages 11-14

  Iacobellis, Gianluca ^a   Singh, Navneet ^a   Sharma, Arya M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiac adiposity; Echocardiography; Epicardial adipose tissue; Epicardial fat

Indexed keywords

ANTIOBESITY AGENT; INTERLEUKIN 1; INTERLEUKIN 6; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIAGNOSTIC PROCEDURE; DIASTOLIC DYSFUNCTION; DISEASE MARKER; ECHOCARDIOGRAPHY; EPICARDIUM; HEART ATRIUM ENLARGEMENT; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN FUNCTION; RELIABILITY; REVIEW; RISK FACTOR; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 33847289632     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340307779939952     Document Type: Review

References (23)

1. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006; 113: 898-918.
2. Fruhbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 197-208.
3. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 5: 1640-1649.
4. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005; 2: 536-543.
5. McGavock J, Victor RU, Roger H, Szczepaniak, LS. Adiposity of the Heart, Revisited. Ann Int Med 2006; 144: 517-524.
6. Iacobellis G. Imaging of visceral adipose tissue: an emerging diagnostic tool and therapeutic target. Curr Drug Targets Cardiovasc Haematol Disord 2005; 5: 345-53.
7. Ross RL, Leger D, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol 1992; 72: 787-795.
8. Iacobellis G, Assael F, Ribaudo MC et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003; 11: 304-310.
9. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94: 225-232.
10. Iacobellis G, Pistilli D, Gucciardo M. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 2005; 29: 251-255.
11. Mazurek T, Zhang L, Zalewski A et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460-2466.
12. Baker AR, Silva NF, Quinn DW et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 13: 1.
13. Chaldakov GN, Fiore M, Stankulov IS, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog Brain Res 2004; 146: 279-89.
14. Kremen J, Dolinkova M, Krajickova J et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006 Aug 8; [Epub ahead of print].
15. Corradi D, Maestri R, Callegari S, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004; 13: 313-316.
16. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 2004; 94: 1084-1087.
17. Iacobellis G, Leonetti F, Singh N, Sharma AM. Relationship of epicardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol 2006 Jun 5; [Epub ahead of print].
18. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects J Clin Endocrinol Metab. 2005; 90: 6300-2.
19. Iacobellis G, Ribaudo MC, Assael F et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88: 5163-5168.
20. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005; 149: 54-60.
21. Carr DB, Utzschneider KM, Hull RL et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-94.
22. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005; 165: 777-783.
23. Lanes R, Soros A, Flores K, Gunczler P, Carrillo E, Bandel J. Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 2005; 90: 3978-82.